Literature DB >> 5755257

[Therapeutic effect of heterologous antihuma lymphocyte serum (AHLS) in chronic lympahtic leukemia].

A D Tsirimbas, R Pichlmayr, B Hornung, H Pfisterer, S Thierfelder, W Brendel, W Stich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5755257     DOI： 10.1007/bf01747837

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  9 in total

1.  INVESTIGATIONS OF THE IMMUNOLOGICAL REACTIVITY IN HAEMOBLASTOSES. III. CIRCULATING ANTIBODY FORMATION AS A RESPONSE TO ANTIGENIC STIMULUS IN LEUKAEMIA, MALIGNANT LYMPHOMA, MYELOMA AND MYELOFIBROSIS.

Authors:  J LIBANSKY
Journal:  Neoplasma       Date:  1963       Impact factor: 2.575

2.  Diffusion-in-gel methods for immunological analysis.

Authors:  O OUCHTERLONY
Journal:  Prog Allergy       Date:  1958

3.  Diffusion-in-gel methods for immunological analysis. II.

Authors:  O OUCHTERLONY
Journal:  Prog Allergy       Date:  1962

4.  The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation.

Authors:  T E Starzl; T L Marchioro; K A Porter; Y Iwasaki; G J Cerilli
Journal:  Surg Gynecol Obstet       Date:  1967-02

5.  [Production of heterologous immune serums against human lymphocytes].

Authors:  R Pichlmayr; W Brendel; G Beck; E Schmittdiel; I Pichlmayr; S Thierfelder; A Fateh-Moghadam; W Land
Journal:  Klin Wochenschr       Date:  1968-03-01

Review 6.  The anaphylactic antibodies of mammals including man.

Authors:  K J Bloch
Journal:  Prog Allergy       Date:  1967

7.  [Antilymphocyte serum therapy in human autoimmune diseases].

Authors:  F Trepel; R Pichlmayr; J Kimura; W Brendel; H Begemann
Journal:  Klin Wochenschr       Date:  1968-08-15

8.  [Preparation and effect of heterologous anti-dog lymphocyte serums].

Authors:  R Pichlmayr
Journal:  Z Gesamte Exp Med       Date:  1967

9.  The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions.

Authors:  Y Iwasaki; K A Porter; J R Amend; T L Marchioro; V Zühlke; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1967-01
  9 in total
  10 in total

1.  [The importance of antilymphocyte serum in immunosuppression].

Authors:  R Pichlmayr
Journal:  Langenbecks Arch Chir       Date:  1968

2.  [The risk of ALG therapy possible side effects: prevention and treatment (author's transl)].

Authors:  J Ring; J Seifert; G Lob; W Land; K Coulin; W Brendel
Journal:  Klin Wochenschr       Date:  1973-05-15

3.  Use of antilymphocyte globulin after cadaveric renal transplantation.

Authors:  P B Doak; N T Dalton; J Meredith; J Z Montgomerie; J D North
Journal:  Br Med J       Date:  1969-11-29

4.  The effect of anti-lymphocyte globulin on human monocytes in vitro.

Authors:  H Huber; G Michlmayr; H H Fudenberg
Journal:  Clin Exp Immunol       Date:  1969-12       Impact factor: 4.330

5.  [Leukotoxic effect of homologous human antileukocyte plasma (HALP)].

Authors:  S Thierfelder; H Pfisterer; A Tsirimbas; W Mempel; B Hornung; M Eulitz; W Stich
Journal:  Klin Wochenschr       Date:  1969-04-01

6.  [The effect of antilymphocyte serum alone or in combination with a cytostatic agent on mouse leukemia].

Authors:  W Mempel; S Thierfelder
Journal:  Blut       Date:  1970-01

7.  [Attempt for an induction of immune tolerance against horse IgG in men].

Authors:  W Land; W Brendel; U Hopf; J Seifert
Journal:  Klin Wochenschr       Date:  1970-02-15

8.  [Serologic studies of patients under treatment with xenogenous antilymphocyte globulin].

Authors:  U Hopf; A Fateh-Moghadam; W Land; W Brendel
Journal:  Klin Wochenschr       Date:  1970-08-01

9.  Fine structure of circulating lymphocytes under the effect of antilymphocyte serum (ALS) in chronic lymphatic leukemia.

Authors:  D Hu; H Pfisterer; K Lani
Journal:  Blut       Date:  1970-05

10.  A trial with heterologous antilymphocyte globulin in man.

Authors:  T E Starzl; L Brettschneider; I Penn; R W Schmidt; P Bell; N Kashiwagi; C M Townsend; C W Putnam
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.